News and Updates

Discover how Agentic AI is transforming oncology by automating clinical trial matching, reducing administrative delays, and improving patient outcomes.

AMO Pharma has secured regulatory alignment for a registrational study of AMO-02 to treat Congenital Myotonic Dystrophy, a critical move for the rare disease.

Explore how real-world data is shaping the use of NALIRIFOX in pancreatic cancer treatment compared to findings from the NAPOLI-3 clinical trial.

Considering a clinical trial? Learn the essential eligibility requirements, logistical hurdles, and safety steps needed to participate in medical research.

A recent study shows a 2.5x increase in cardiac emergencies among young adults post-COVID, highlighting critical risks of myocardial and vascular damage.

Can biological age be measured by DNA? We analyze the FDA's current stance on epigenetic clocks and what they mean for the future of longevity medicine.

Discover how Agentic AI is reducing cognitive load for oncologists and accelerating clinical trial matching for improved patient recruitment outcomes.

Ochsner Health and Paradigm join forces to increase clinical trial access in the Gulf South, bridging the gap for patients to access life-saving research.

Explore the benefits and hurdles of remote heart failure monitoring. Discover how telehealth is reshaping cardiology and improving patient outcomes.

The FDA is calling for public input on AI medical device regulations. Learn how these new standards will impact algorithm safety, updates, and innovation.